Average Co-Inventor Count = 7.26
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Chemocentryx, Inc. (105 from 214 patents)
2. Millennium Pharmaceuticals Limited (14 from 847 patents)
3. Amgen Inc. (3 from 1,960 patents)
4. Other (1 from 832,398 patents)
5. Cor Therapeutics, Inc. (1 from 92 patents)
124 patents:
1. 12448373 - Azetidinyl-acetamides as CXCR7 inhibitors
2. 12371433 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases
3. 12268675 - Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors
4. 12139475 - 2-oxindole compounds
5. 12054484 - Substituted tetrahydropyrans as CCR2 modulators
6. 12018016 - Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors
7. 12012403 - Aryl sulfonyl compounds as CCR6 inhibitors
8. 12011439 - Combination therapy using C—C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors
9. 11945805 - Inhibitors of CXCR2
10. 11883391 - Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-IL-23 blocking antibodies
11. 11872217 - Indanes as PD-L1 inhibitors
12. 11866429 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases
13. 11845729 - Processes and intermediates in the preparation of C5aR antagonists
14. 11834452 - CXCR7 antagonists
15. 11820759 - Modulators of chemokine receptors